PQS Trend Report Examines Socio-Demographic and Utilization Factors Related to Medication Adherence
DURHAM, NC / ACCESSWIRE / December 4, 2023 / Pharmacy Quality Solutions (PQS), a leading provider of performance management services,...
Medicare
Cardio Diagnostics Holdings, Inc’s Convenes Cardiovascular Care & Risk Roundtable at the 42nd Annual J.P. Morgan Healthcare Conference
The roundtable will bring together healthcare stakeholders to discuss operationalizing value-based care with novel risk-stratification strategies in the cardiovascular disease...
Cardio Diagnostics Holdings, Inc’s Convenes Cardiovascular Care & Risk Roundtable at the 42nd Annual J.P. Morgan Healthcare Conference
The roundtable will bring together healthcare stakeholders to discuss operationalizing value-based care with novel risk-stratification strategies in the cardiovascular disease...
CrossTx Powers Successful Quality Improvement Initiative in Peer-Reviewed Journal
CrossTx was featured in the peer-reviewed journal Nursing Economics in the September-October 2023 edition in a report that advanced rural...
Expanded Program Benefits 62 Million Vulnerable Americans With Limited Access To Healthcare
Cellular remote patient monitoringTM will be a reimbursable care service for Federally Qualified Health Centers and Rural Health Clinics in...
Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea
With this unprecedented FDA clearance, Vivos redefines what it means to have a truly non-invasive treatment for all levels of...
BioCardia Shares Update from Japan PMDA Consultation on CardiAMP Autologous Cell Therapy for Ischemic Heart Failure; Foreign Data Expected to be Sufficient for Product Approval
SUNNYVALE, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- BioCardia, Inc. , a developer of cellular and cell-derived therapeutics for the...
Royal Biologics Announces Commerical Launch of Derm-Maxx(TM) and Newly Formed Wound Care Division
HACKENSACK, NJ / ACCESSWIRE / November 28, 2023 / Royal Biologics, Inc., a company specializing in Advanced Cellular & Autologous...
ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype
R&D Grant from the Israeli Technology Innovation Consortium Enabled the Successful Demonstration of a Working Prototype MARLBOROUGH, Mass. and BERLIN...
iCAD’s ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease
New research presented at Radiological Society of North America annual meeting confirms ability of ProFound Breast Health Suite to predict...
Louisiana Insurer Expands Deep TMS™ Access for 1.9 Million Covered Lives
BURLINGTON, Mass. and JERUSALEM, Nov. 20, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
NextGen Healthcare Value-Based Care Solutions Help Unlock $82 Million in Medicare Savings
Innovative Data Analytics Solution Enables Healthcare Organizations to Better Serve Medicare ACO BeneficiariesREMOTE-FIRST COMPANY/WICHITA, Kan.--(BUSINESS WIRE)--#NextGenHealthcare--NextGen Healthcare, Inc. a leading...
CMS Sets Pricing with New HCPCS Codes for eXciteOSA Therapy, Expanding Access to Innovative Daytime Sleep Apnea Treatment
BOSTON & LONDON--(BUSINESS WIRE)--Signifier Medical Technologies LLC (“Signifier” or the “Company”), a Boston-based medical technology company, welcomes the recent announcement...
ReWalk Robotics Reports Third Quarter 2023 Financial Results
Record Quarterly Revenue of $4.4 Million Successful Completion of AlterG Acquisition and Significant Progress of Integration Major Advancement in Efforts...
iCAD to Participate in the 14th Annual Craig-Hallum Alpha Select Conference
NASHUA, N.H., Nov. 14, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create...
BioCardia Announces FDA Approval of CardiAMP Heart Failure II Protocol for Autologous Cell Therapy for Ischemic Heart Failure
SUNNYVALE, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- BioCardia, Inc. , a developer of cellular and cell-derived therapeutics for the...
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024
LONDON and SALT LAKE CITY, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled...
Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company Update
Company continues to advance launch, reports initial revenue from Omisirge® (omidubicel-onlv) Company to host conference call today at 8:30 a.m....
Apollo Medical Holdings, Inc. to Participate in Upcoming Investor Conference
ALHAMBRA, Calif., Nov. 13, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities,...
In Shocking Reversal, CMS Wants to Allow Medicare Part D Plan Sponsors to Substitute Non-Interchangeable Biosimilars
WASHINGTON, DC / ACCESSWIRE / November 10, 2023 / On November 6, 2023, the Centers for Medicare and Medicaid Services...